11th International Conference on cGMP


cGMP: Generators, Effectors and
Therapeutic Implications

Pre-final Program (last updated: March 12, 2024)

All titles in italics are preliminary and will be updated in April or even earlier

Friday, June 28, 2024

13:00-13:55 Registration & Welcome Reception
13:55 Harald Schmidt,
Maastricht
Welcome to Lübeck
S1 | Session 1:
Clinical Translation
Chairs:
Peter Sandner, Wuppertal
Mark Gladwin, Maryland
S1-01 14:00 Dominik Steubl,
Ingelheim
sGCa BI685509 in chronic kidney disease - results from a Phase 2 clinical trial
S1-02 14:20 Karen Paraschin,
Wuppertal
The sGC Activator runcaciguat reduces albuminuria in patients with chronic kidney disease (CKD): Results from the phase 2 CONCORD study
S1-03 14:40 Rafael De la Espriella,
Valencia
NOS recoupling with L-citrulline, folate, and vericiguat in a NOX5-positive subgroup of HFpEF patients: A Phase IIa proof-of-concept trial
S1-04 15:00 Essam Metwally,
Rahway
Structural insights into selective small molecule activation of PKG1α
S2 | Session 2:
cGMP in the Cardiovascular System
Chairs:
Friederike Cuello, Hamburg
Robert Lukowski, Tübingen
S2-01 15:20 Miriam Cortese-Krott,
Düsseldorf
The role of NO/sGC signalling in erythropoiesis
S2-02 15:40 Amie Moyes,
London
CNP regulates cardiac and vascular function in sepsis
S2-03 16:00 Marie-Ange Renault,
Bordeaux
sGC is a promising therapeutic target for the management of lower limb ischemia
S2-04 16:20 N.N.
t.b.a
16:40-17:00 COFFEE BREAK
S3 | Session 3:
cGMP in Cancer Biology (and Metabolism)
Chairs:
Franz Hofmann, München
Michael Marletta, Berkeley
S3-01 17:00 Donald P. McDonnell,
Durham
Manipulation of cancer cell intrinsic and extrinsic cGMP signaling as a therapeutic approach in cancer
S3-02 17:20 Robert Feil,
Tübingen
NO/cGMP signaling in the tumor micro­environment
S3-03 17:40 N.N.
t.b.a.
18:00–19:00 SNACK AND REFRESHMENTS
MML | Ferid Murad
Memorial Lecture
Chair:
Sheila Collins, Nashville
MML-01
19:00-19:45
Alexander Pfeifer,
Bonn
Regulation of Metabolism by cGMP: Focus on adipose tissue and obesity
19:45–22:00 POSTER SESSION I


Saturday, June 29, 2024

S4 | Session 4:
NO-GC Structure, Modulators, Function
Chairs:
Miriam Cortese-Krott, Düsseldorf
Andreas Friebe, Würzburg
S4-01 08:30 N.N.
t.b.a.
S4-02 08:50 Michael Marletta,
Berkley
Molecular aspects of sGC activation and stimulator function
S4-03 09:10 Jon O. Lundberg,
Stockholm
Is NO-ferroheme a signalling entity?
S4-04 09:30 Mark Gladwin,
Maryland
NO-ferroheme regulates intravascular NO/cGMP via NO-GC
S4-05 09:50 Thorsten Kessler,
München
cGMP in athero­sclerosis: genetic and mechanistic insights
10:10-10:40 COFFEE BREAK
S5 | Session 5:
Emerging Fields
Chairs:
Peter Sandner, Wuppertal
Robert Lukowski, Tübingen
S5-01 10:40 N.N.
t.b.a.
S5-02 10:55 N.N.
t.b.a.
S5-03 11:10 N.N.
t.b.a.
S5-04 11:25 N.N.
t.b.a.
11:40–13:30 SNACK AND REFRESHMENTS
  POSTER SESSION II
13:30-17:00 FREE TIME
17:00-17:15 COFFEE BREAK
S6 | Session 6:
Crosstalk
Chairs:
Robert Feil, Tübingen
Michaela Kuhn, Würzburg
S6-01 17:15 John Pernow,
Stockholm
Cardio­protective effects of erythrocytes mediated by soluble guanylate cyclase and release of cGMP
S6-02 17:35 Viacheslav O. Nikolaev,
Hamburg
Regulation of cardiac contractility and hypertrophy by cGMP nanodomains
S6-03 17:55 Michael Russwurm,
Potsdam
NO-induced cGMP in the heart: Role of Phospho­die­sterases in physiology and patho­physiology
S6-04 18:15 N.N.
t.b.a.
18:35-20:15 SNACK AND REFRESHMENTS
POSTER SESSION IIIa
EL | Evening Lecture Chair:
Harald Schmidt, Maastricht
EL-01
20:15-21:00
Joseph Loscalzo,
Boston
Network Approach to Drug Target Identification and Drug Combinations: Implications for cGMP-based Therapeutics
21:00-22:00 POSTER SESSION IIIb


Sunday, June 30, 2024

S7 | Session 7:
Non-canonical Signaling and Novel Aspects
Chairs:
Johannes-Peter Stasch, München     
Michael Russwurm, Potsdam
S7-01 08:50 Jean-Pierre Saint-Jeannet,
New York
The functions of Npr3 during embryonic development
S7-02 09:10 Sheila Collins
Nashville
Natriuretic Peptide Signaling – Some Old, Some New – and Roles in Adipose Biology
S7-03 09:30 N.N.
t.b.a.
09:50-10:10 COFFEE BREAK
S8 | Session 8:
Natriuretic Peptides, their Receptors and beyond
Chairs:
Viacheslav O. Nikolaev, Hamburg
Sheila Collins, Nashville
S8-01 10:10 Valentina Cannone,
Parma
MANP: A natriuretic peptide-based therapy for cardiometabolic diseases
S8-02 10:30 Michaela Kuhn,
Würzburg
Endothelial natriuretic peptide receptor-C: All clear?
S8-03 10:50 Susanne Kämmerer,
Dresden
cGMP-induced PDE2 stimulation as a novel antiar­rhythmic strategy
S8-04 11:10 Eric Schneider,
San Fransico
Development of a long acting­ C-natriuretic peptide suitable for QMo dosing
S8-05 11:30 N.N.
t.b.a.
11:50-13:00 SNACKS AND REFRESHMENTS
  POSTER SESSION IV
S9 | Session 9:
Technological Advances & New Applications
Chairs:
Harald Schmidt, Maastricht
Susanne Kämmerer, Dresden
S9-01 14:50 Jian Yang,
New York
Conformational landscape of cGMP activation of the human cone photoreceptor CNG channel
S9-02 15:10 Purnima Bhanot,
New Jersey
PfPKG inhibitors for malaria chemo prevention
S9-03 15:30 N.N.
t.b.a.
15:50-16:20 COFFEE BREAK
S10 | Session 10:
Special session of the DGPT
Chair:
Roland Seifert, Hannover
S10-01 16:20 Naunyn-Schmiedeberg Prize awarded by the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT)
S11 | Session 11:
Poster Presentations “Rapid Fire”
Chairs:
Miriam Cortese-Krott, Düsseldorf
Adrian Hobbs, London
S11-01 16:40 3 to 5 selected posters 5 minute rapid fire oral presentations of selected posters
17:15-18:00 ORAL & POSTER PRIZE COMMITTEE MEETINGS
18:45-23:00 AWARD DINNER & CEREMONY

home | scientific organizers | city | program | further information | abstracts | registration | accomodation | sponsors | impressum | privacy